Plain-English translation of NCT07431983 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is comparing intestinal bowel ultrasound (IBUS)—a simple, portable imaging technique—to the standard imaging tests you would normally receive for inflammatory bowel disease. The study wants to understand whether this ultrasound method works just as well as colonoscopy or CT/MRI scans at detecting disease activity, while also using much less energy and producing less waste.
Standard imaging tests like colonoscopy and CT scans require a lot of electricity, sterilization, and transportation, which adds to healthcare's environmental footprint. Researchers want to see if the newer ultrasound approach can give doctors the same useful information about your disease while being gentler on the environment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive both the standard imaging test your doctor normally recommends (colonoscopy for ulcerative colitis, or CT/MRI for Crohn's disease) and an additional intestinal ultrasound scan. The researchers will compare how well both methods detect your disease activity and measure the energy and resources each one uses. Your participation helps doctors understand whether ultrasound could become a reliable first-line tool for monitoring inflammatory bowel disease in the future.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
India
Sponsor
Asian Institute of Gastroenterology, India
Enrollment target
~200 participants
Started
March 2026
Primary completion
December 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr.Hardik Rughwani
Asian Institute of Gastroenterology, India
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.